The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Maderazo Alan Baer since 2020.
This trader's CIK number is 1811984.
At the time of last reporting, Maderazo Alan Baer was the VP, Qual, Reg, & Clin Affairs of Genmark Diagnostics, Inc.. (stock ticker symbol GNMK).
Also see all insider trading activities at Genmark Diagnostics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2021 | GNMK | 0 | $0 | 37,824 | $562,247 | 65,185 | $0 |
| 2020 | GNMK | 0 | $0 | 96,730 | $1,423,523 | 58,680 | $724,874 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2021-03-01 | GNMK | Sale | 2,127 | 19.19 | 40,817 |
| 2021-02-25 | GNMK | Sale | 266 | 19.16 | 5,096 |
| 2021-02-24 | GNMK | Sale | 163 | 19.12 | 3,116 |
| 2021-02-22 | GNMK | Sale | 290 | 20.36 | 5,904 |
| 2021-01-26 | GNMK | Sale | 6,214 | 15.19 | 94,390 |
| 2021-01-25 | GNMK | Sale | 23,764 | 14.22 | 337,924 |
| 2021-01-21 | GNMK | Option Ex | 65,185 | .00 | 0 |
| 2021-01-20 | GNMK | Sale | 5,000 | 15.00 | 75,000 |
| 2020-12-21 | GNMK | Sale | 15,000 | 15.00 | 225,000 |
| 2020-11-25 | GNMK | Sale | 552 | 12.72 | 7,021 |
| 2020-11-24 | GNMK | Sale | 1,994 | 13.17 | 26,260 |
| 2020-11-20 | GNMK | Sale | 366 | 13.01 | 4,761 |
| 2020-11-19 | GNMK | Sale | 1,310 | 13.85 | 18,143 |
| 2020-10-07 | GNMK | Option Ex | 58,680 | 12.35 | 724,874 |
| 2020-10-07 | GNMK | Sale | 69,749 | 15.00 | 1,046,235 |
| 2020-08-27 | GNMK | Sale | 891 | 13.10 | 11,672 |
| 2020-08-25 | GNMK | Sale | 2,130 | 14.14 | 30,118 |
| 2020-08-20 | GNMK | Sale | 1,353 | 15.41 | 20,849 |
| 2020-05-28 | GNMK | Sale | 2,066 | 9.52 | 19,668 |
| 2020-05-19 | GNMK | Sale | 1,319 | 10.46 | 13,796 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Maderazo Alan Baer (VP, Qual, Reg, & Clin Affairs of Genmark Diagnostics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.